臨床検査56巻10号

2012年10月発行

記事購入ページに移動

今月の主題 鉄代謝のバイオマーカー 各論 〈疾患と鉄代謝〉

わが国における遺伝性鉄過剰症の遺伝子診断

著者： 巽康彰¹ 服部亜衣¹ 加藤宏一¹ 林久男¹

所属機関： ¹愛知学院大学薬学部薬物治療学講座

ページ範囲：P.1103 - P.1109

わが国の遺伝性鉄過剰症の分子病態も一部で明らかになった．白人の古典型ヘモクロマトーシスであるHFEのC282Yは1人，他にHFEの新規変異の1人が確認された．若年型の遺伝子であるHJVの変異は4家系の8人で確認された．その一部の臨床病型は古典型であった．最近HAMPの変異による若年型が1人確認された．わが国の主な古典型であるTFR2の変異は，5家系の7人で確認された．フェロポルチン病は，SLC40A1の変異が，3家系の4人で確認された．フェリチンH鎖のFTH1の変異による鉄過剰は，1家系の3人が確認されている．多くは常染色体性劣性遺伝であるが，フェロポルチン病とフェリチン異常症は優性である．無セルロプラスミン血症は日本発の特異な鉄過剰症であり補足した．

参考文献

1) Feder JN, Gnirke A, Thomas W, et al : A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet　13：399-408，1996

2) Kawabata H, Yang R, Hirama T, et al : Molecular cloning of transferrin receptor 2．A new member of the transferrin receptor-like family. J Biol Chem　274：20826-20832，1999

3) Camaschella C, Roetto A, Cali A, et al : The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22．Nat Genet　25：14-15，2000

4) Papanikolaou G, Politou M, Roetto A, et al : Linkage to chromosome 1q in Greek families with juvenile hemochromatosis. Blood Cells Mol Dis　27：744-749，2001

5) Papanikolaou G, Samuels ME, Ludwig EH, et al : Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet　36：77-82，2004

6) Roetto A, Papanikolaou G, Politou M, et al : Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet　33：21-22，2003

7) Njajou OT, Vaessen N, Joosse M, et al : A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet　28：213-214，2001

8) Montosi G, Donovan A, Totaro A, et al : Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest　108：619-623，2001

9) Kato J, Fujikawa K, Kanda M, et al : A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet　69：191-197，2001

10) Miyajima H, Nishimura Y, Mizoguchi K, et al : Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology　37：761-767，1987

11) Kaneko Y, Miyajima H, Piperno A, et al : Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders. J Gastroenterol　45：1163-1171，2010

12) Sohda T, Yanai J, Soejima H, et al : Frequencies in the Japanese population of HFE gene mutations. Biochem Genet　37：63-68，1999

13) Shiono Y, Ikeda R, Hayashi H, et al : C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan. Intern Med　40：852-856，2001

14) Sohda T, Okubo R, Kamimura S, et al : Hemochromatosis with HFE gene mutation in a Japanese patient. Am J Gastroenterol　96：2487-2488，2001

15) Shiono Y, Hayashi H, Wakusawa S, et al : Body iron stores and iron restoration rate in Japanese patients with chronic hepatitis C as measured during therapeutic iron removal revealed neither increased body iron stores nor effects of C282Y and H63D mutations on iron indices. Nagoya J Med Sci　64：51-57，2001

16) Takano A, Niimi H, Atarashi Y, et al : A novel Y231del mutation of HFE in hereditary haemochromatosis provides in vivo evidence that the Huh-7 is a human haemochromatotic cell line. Liver Int　31：1593-1597，2011

17) Koyama C, Hayashi H, Wakusawa S, et al : Three patients with middle-age-onset hemochromatosis caused by novel mutations in the hemojuvelin gene. J Hepatol　43：740-742，2005

18) Nagayoshi Y, Nakayama M, Suzuki S, et al : A Q312X mutation in the hemojuvelin gene is associated with cardiomyopathy due to juvenile haemochromatosis. Eur J Heart Fail　10：1001-1006，2008

19) Maeda T, Nakamaki T, Saito B, et al : Hemojuvelin hemochromatosis receiving iron chelation therapy with deferasirox : improvement of liver disease activity, cardiac and hematological function. Eur J Haematol　87：467-469，2011

20) Hattori A, Tomosugi N, Tatsumi Y, et al : Identification of a novel mutation in the HAMP gene that causes non-detectable hepcidin molecules in a Japanese male patient with juvenile hemochromatosis. Blood Cells Mol Dis　48：179-182，2012

21) Hattori A, Wakusawa S, Hayashi H, et al : AVAQ 594-597 deletion of the TfR2 gene in a Japanese family with hemochromatosis. Hepatol Res　26：154-156，2003

22) Girelli D, Bozzini C, Roetto A, et al : Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. Gastroenterology　122：1295-1302，2002

23) Koyama C, Wakusawa S, Hayashi H, et al : Two nevel mutations, L490R and V561X, of the transferrin receptor 2 gene in Japanese patients with hemochromatosis. Haematologica　90：302-307，2005

24) 土田健一，種田紳二，三澤和史，他：糖尿病，下垂体性性腺機能低下症，肝線維化を呈した新規TfR2遺伝子変異による原発性ヘモクロマトーシス(HH Type 3)の1例．糖尿病　53：247-252，2010

25) Roetto A, Totaro A, Piperno A, et a1 : New mutations inactivating transferrin receptor 2 in hemochromatosis type 3．Blood　97：2555-2560，2001

26) Barton EH, West PA, Rivers CA, et al : Transferrin receptor-2 (TFR2) mutation Y250X in Alabama Caucasian and African American subjects with and without primary iron overload. Blood Cells Mo1 Dis　27：279-284，2001

27) Lee PL, Halloran C, West C, et al : Mutation analysis of the transferrin receptor-2 gene in patients with iron overload. Blood Cells Mol Dis　27：285-289，2001

28) Koyama C, Wakusawa S, Hayashi H, et al : A Japanese family with ferroportin desease caused by a novel mutation of SLC40A1 gene : hyperferritinemia associated with a relatively low transferrin saturation of iron. Intern Med　44：990-993，2005

29) Liu W, Shimomura S, Imanishi H, et al : Hemochromatosis with mutation of the ferroportin 1 (IREG1) gene. Intern Med　44：285-289，2005

30) Gordeuk VR, Caleffi A, Corradini E, et al : Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. Blood Cells Mol Dis　31：299-304，2003

31) Beutler E, Barton JC, Felitti VJ, et al : Ferroportin 1 (SCL40A1) variant associated with iron overload in Aftican-Americans. Blood Cells Mol Dis　31：305-309，2003

32) Cremonesi L, Forni GL, Soriani N, et al : Genetic and clinical heterogeneity of ferroportin disease. Br J Haematol　131：663-670，2005

33) McNeill A, Pandolfo M, Kuhn J, et al : The neurological presentation of ceruloplasmin gene mutations. Eur Neurol　60：200-205，2008